Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

Item

http://www.wikidata.org/entity/Q37373616

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

@en

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

@nl

type

Item

label

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

@en

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

@nl

prefLabel

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

@en

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

@nl

P1476

Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.

@en

P2093

D N Yarde

http://www.w3.org/2001/XMLSchema#string

K-W Peng

http://www.w3.org/2001/XMLSchema#string

M J Federspiel

http://www.w3.org/2001/XMLSchema#string

R A Nace

http://www.w3.org/2001/XMLSchema#string

S J Russell

http://www.w3.org/2001/XMLSchema#string

S Naik

http://www.w3.org/2001/XMLSchema#string

P2860

How cells respond to interferons

Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting.

Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy.

Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates

A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice.

VSV-tumor selective replication and protein translation.

Emergence and re-emergence of vesicular stomatitis in the United States.

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.

P2888

cgt.2013.63

P304

616-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2013.63

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258213747

http://www.w3.org/2001/XMLSchema#string

P698

24176894

http://www.w3.org/2001/XMLSchema#string

P932

3855306

http://www.w3.org/2001/XMLSchema#string